References
- Alexanderson B., Price Evans D. A., Sjöqvist F. Steady‐state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Brit. Med. J. 1969; 764–768
- Altschuler S. L., Valenteen J. W. Amenorrhea following rifampicin administration during oral contraceptive use. Obstet. Gynecol. 1974; 44: 771–772, [PUBMED], [INFOTRIEVE]
- Back D. J., Breckenridge A. M., Orme M. L. Drug interactions with oral contraceptive steroids. IPPF Med. Bull. 1983; 17: 1–2, [PUBMED], [INFOTRIEVE]
- Bertilsson G., Heidrich J., Svensson K., Asman M., Jendeberg L., Sydowbackman M., Ohlsson R., Postlind H., Blomqvist P., Berkenstam A. Identification of a human nuclear receptor defines a new signalling pathway for CYP3A induction. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 12208–12213, [PUBMED], [CSA], [CROSSREF]
- Blumberg B., Kang K., Bolado J., Chen H., Craig A., Moreno T., Umesono K., Perlmann T., DeRobertis E., Evans R. BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. Genes Dev. 1998; 12: 1269–1277, [PUBMED]
- Bolt H. M. Metabolism of estrogens: natural and synthetic. Pharm. Ther. 1979; 4: 155–181, [CROSSREF]
- Bolt H. M. Drug interactions involving oral contraceptives. Rev. Drug Metab. Drug Interact. 1980; 3: 31–45
- Bolt H. M. Interactions between clinically used drugs and oral contraceptives. Environ. Health Perspect. 1994; 102(Suppl. 9)35–38, [PUBMED]
- Bolt H. M., Kappus H. Effect of clotrimazol treatment on the demethylation of mestranol. Horm. Metab. Res. 1973; 5: 234, [PUBMED], [INFOTRIEVE]
- Bolt H. M., Bolt W. H. Pharmacokinetics of mestranol in relation to its oestrogenic activity. Eur. J. Clin. Pharmacol. 1974a; 7: 295–305, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bolt H. M., Bolt M. Die Wirkungsinterferenzen zwischen Rifampicin und oralen Kontrazeptiva. Internist 1974b; 15: 571–572, [PUBMED], [INFOTRIEVE]
- Bolt H. M., Remmer H. Implication of rifampicin‐quinone in the irreversible binding of rifampicin to macromolecules. Xenobiotica 1976; 6: 21–32, [PUBMED], [INFOTRIEVE]
- Bolt H. M., Kappus H., Bolt M. Effect of rifampicin treatment on the metabolism of oestradiol and 17‐alpha‐ethinyl‐oestradiol by human liver microsomes. Eur. J. Clin. Pharmacol. 1975; 8: 301–307, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bolt H. M., Bolt M., Kappus H. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol. 1977; 85: 189–197, [PUBMED], [INFOTRIEVE]
- Brodie B. B., Axelrod J. The fate of antipyrine in man. J. Pharm. (Baltimore) 1950; 98: 97–104
- Buffington G. A., Dominguez J. H., Piering W. F., Hebert L. A., Kauffman M., Lemann J. Interaction of rifampicin and glucocorticoids. J. Am. Med. Assoc. 1976; 236: 1958–1960, [CROSSREF]
- Butler T. C., Mahaffe C., Wadell C. W. Phenobarbital: studies of elimination, accumulation, tolerance, and dosage schedules. J. Pharmacol. Exp. Ther. 1954; 111: 425–435, [PUBMED], [INFOTRIEVE]
- Chen Y., Ferguson S. S., Negishi M., Goldstein J. A. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J. Pharmacol. Exp. Ther. 2004; 308: 495–501, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Daujat M., Pichard L., Fabre I., Pineau T., Fabre G., Bonfils C., Maurel P. Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods Enzymol. 1991; 206: 345–353, [PUBMED], [INFOTRIEVE]
- Dussault I., Yoo H.‐D., Lin M., Wang E., Fan M., Batta A. K., Salen G., Erickson S. K., Forman B. M. Identification of an endogenous ligand that activates pregnane X receptor‐mediated sterol clearance. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 833–838, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Edwards O. M., Courtenay‐Evans R. J., Galley J. M., Hunter J., Tait A. D. Changes in cortisol metabolism following rifampicin treatment. Lancet 1974; 2: 549–551, [CROSSREF]
- Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampicin. J. Biol. Chem. 2001; 276: 14587–14851, [CROSSREF]
- Goodwin B., Hodgson E., Liddle C. The orphan human pregnan X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol. 1999; 56: 1329–1339, [PUBMED], [INFOTRIEVE], [CSA]
- Guengerich F. P. Inhibition of oral contraceptive steroid‐metabolizing enzymes by steroids and drugs. Am. J. Obstet. Gynecol. 1990a; 1–3: 2159–2163
- Guengerich F. P. Mechanism‐based inactivation of human liver microsomal cytochrome P‐450 III A4 by gestodene. Chem. Res. Toxicol. 1990b; 3: 363–371, [PUBMED], [INFOTRIEVE]
- Guengerich F. P. Metabolism of 17 alpha‐ethynylestradiol in humans. Life Sci. 1990c; 47: 1981–1988, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Helton E. D., Goldzieher J. W. Metabolism of ethynyl estrogens. J. Toxicol. Environ. Health 1977; 3: 231–241, [PUBMED], [INFOTRIEVE]
- Jones S. A., Moore L. B., Shenk J. L., Wisely G. B., Hamilton G. A., McKee D. D., Tomkinson N. C.O., LeCluyse E. L., Lambert M. H., Willson T. M., Kliewer S. A., Moore J. T. The pregnane X receptor, a promiscuous nuclear xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 2000; 14: 27–39, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kliewer S. A., Moore J. T., Wade L., Staudinger J. L., Watson M. A., Jones S. A., McKee D. D., Oliver B. B., Willson T. M., Zetterstrom R. H., Perlmann T., Lehmann J. M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway. Cell 1998; 92: 73–82, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kozarek T. A., Schuetz E. G., Strom S. C., Fisher R. A., Guzelian P. S. Comparative analysis of cytochrome P450 3A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metab. Dispos. 1995; 23: 415–421, [CSA]
- Kropp R. Rifampicin und Ovulationshemmer. Prax. Pneumologie 1974; 28: 270–272
- Kulkarni B. D., Goldzieher J. W. A preliminary report on urinary excrerion pattern and method of isolation of 14C‐ethynylestradiol metabolites in women. Contraception 1970; 1: 47–55, [CROSSREF]
- Lafaix C., Cadoz M., Richard A., Patouillard P. Effet “antipilule” de la rifampicine. Med. Hyg. (Genève) 1976; 34: 181–182
- Lay B., Hildebrandt A. G., Roots I. The specificity of response of in vitro parameters of drug metabolism to different enzyme inducers in the Guinea pig. Naunyn‐Schmiedeberg's Arch. Pharmacol. Suppl. 1976; 293: R52
- LeCluyse E. L. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chem. Biol. Interact. 2001; 134: 283–289, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lehmann J., McKee D., Watson M., Willson T., Moore J., Kliewer S. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 1998; 102: 1016–1023, [PUBMED], [INFOTRIEVE], [CSA]
- Li A. P., Kaminski D. L., Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995; 104: 1–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Liddle C., Goodwin B. J., George J., Tapner M., Farrell G. C. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J. Clin. Endocrinol. Metab. 1998; 83: 2411–2416, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mae T., Hosoe K., Yamamoto T., Hidaka T., Ohashi T., Kleeman J. M., Adams P. E. Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog. Xenobiotica 1998; 28: 759–766, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Michot F., Bürgi M., Büttner J. Rimactan (Rifampicin) und Antikoagulantientherapie. Schweiz. Med. Wochenschr. 1970; 100: 583–584, [PUBMED], [INFOTRIEVE]
- Moore J. T., Kliewer S. A. Use of the nuclear receptor PXR to predict drug interactions. Toxicology 2000; 153: 1–10, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nocke‐Finck L., Breuer H., Reimers D. Wirkung von Rifampicin auf den Menstruationszyklus und die Östrogenausscheidung bei Einnahme oraler Kontrazeptiva. Dtsch. Med. Wochenschr. 1973; 98: 1521–1523
- Olsen A. K., Hansen K. T., Friis C. Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug‐drug interactions with 17‐alpha‐ethynylestradiol. Chem. Biol. Interact. 1997; 107: 93–108, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Otani G., Remmer H. The role of microsomal NADPH‐cytochrome reductase in the metabolism of rifampicin. Naunyn‐Schmiedeberg's Arch. Pharmacol. Suppl. 1975; 287: R76, [CSA]
- Pessayre D., Mazel P. Induction and inhibition of hepatic drug metabolizing enzymes by rifampicin. Biochem. Pharmacol. 1976; 25: 943–945, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Peters U., Hausamen T. U., Grosse‐Brockhoff F. Einfluss von Tuberkulostatika auf die Pharmakokinetik des Digitoxins. Dtsch. Med. Wochenschr. 1974; 99: 2381–2386, [PUBMED], [INFOTRIEVE]
- Quinn C. P., Axelrod J., Brodie B. B. Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine, and aniline. Biochem. Pharmacol. 1958; 1: 152–159, [CROSSREF]
- Rae J. M., Johnson M. D., Lippman M. E., Flockhart D. A. Rifampicin is a selective, pleiotropic inducer of drug metabolism: studies with cDNA and oligonucleotide expression assays. J. Pharacol. Exp. Ther. 2001; 299: 849–857
- Reimers D., Jezek A. Rifampicin und andere Antituberkulotika bei gleichzeitiger oraler Kontrazeption. Prax. Pneumologie 1971; 25: 255–262
- Remmer H., Hirschmann J., Greiner I. Die Bedeutung von Kumulation und Elimination für die Dosierung von Phenytoin (Diphenylhydantoin). Dtsch. Med. Wschr. 1969; 94: 1265–1272, [PUBMED], [INFOTRIEVE]
- Remmer H., Schoene B., Fleischmann R. A. Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab. Dispos. 1973a; 1: 224–230, [PUBMED], [INFOTRIEVE]
- Remmer H., Schoene B., Fleischmann R. A., Held H. Induction of the unspecific microsomal hydroxylase in the human liver. The Liver. Quantitative Aspects of Structure and Function. Karger, Basel 1973b; 232–239
- Schoene B., Fleischmann R. A., Remmer H., v. Oldershausen H. F. Determination of drug metabolizing enzymes in needle biopsies of human liver. Europ. J. Clin. Pharmacol. 1972; 4: 65–73
- Schuetz E. G., Schuetz J. D., Strom S. C., Thompson M. T., Fisher R. A., Molowa D. T., Li D., Guzelian P. S. Regulation of human liver cytochromes P‐450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 1993; 18: 1254–1262, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Self T. H., Mann R. B. Warfarin and rifampicin interaction. Chest 1975; 67: 490–491, [PUBMED], [INFOTRIEVE]
- Skolnick J. L., Stoler B. S., Katz D. B., Anderson W. H. Rifampicin, oral contraceptives, and pregnancy. JAMA 1976; 236: 1382, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Snyder R., Remmer H. Classes of hepatic microsomal mixed function oxidase inducers. Pharm. Ther. 1979; 7: 203–244, [CROSSREF]
- Solymoss B., Werringloer J., Toth S. The influence of pregnenolone‐16α‐carbonitrile on hepatic mixed‐function oxygenases. Steroids 1971; 17: 427–433, [PUBMED], [INFOTRIEVE]
- Syvälahti E. R., Pihlajamäki K. K., Lisalo E. J. Rifampicin and drug metabolism. Lancet 1974; 2: 232–233
- Teng S., Jekerle V., Piquette‐Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab. Dispos. 2003; 31: 1296–1299, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thier R., Brüning T., Roos P. H., Bolt H. M. Cytochrome P450 1B1, a new keystone in gene environment interactions related to human head and neck cancer?. Arch. Toxicol. 2002; 76: 249–256, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vesell E. S., Page J. G. Genetic control of drug levels in man: phenylbutazone. Science 1968; 159: 1479–1480, [PUBMED], [INFOTRIEVE]
- Vessell E. S., Page J. G., Passananti G. T. Genetic and environmental factors affecting ethanol metabolism in man. Clin. Pharm. Ther. 1971; 12: 192–201
- Waxman D. J., Lapenson D. P., Aoyama T., Gelboin H. V., Gonzalez F. J., Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA‐expressed human cytochromes P450s. Arch. Biochem. Biophys. 1991; 290: 160–166, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Williams M. C., Helton E. D., Goldzieher J. W. The urinary metabolites of 17‐alpha‐ethynylestradiol in women. Steroids 1975; 25: 229–246, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yamada S., Iwai K. Induction of hepatic cortisol‐6‐hydroxylase by rifampicin. Lancet 1976; 2: 366, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zilly W., Breimer D. D., Richter R. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur. J. Clin. Pharmacol. 1975; 9: 219–227, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zilly W., Breimer D. D., Richter E. Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance. Eur. J. Clin. Pharmacol. 1977; 11: 287–293, [PUBMED], [INFOTRIEVE], [CROSSREF]